DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The “Global Neuromodulation Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.
The global neuromodulation market is expected to register a CAGR of about 14% over the forecast period 2018-2023.
Increase in the Aging Population to Fuel Market GrowthNeurological diseases are frequent in older adults, affecting around 55% of people age 55 and older. Degenerative diseases, like dementia and Parkinson’s disease, as well as strokes and headaches are frequently encountered neurological diseases in elderly patients.Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment of the neurological most of the diseases, like bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population. The proven efficacy and improving acceptance of this technology will lead to the surge in the market size during the forecast period.Other factors that will affect the growth of the market positively include rising prevalence of neurological disorders to spur market growth, strong product pipeline to propel the market, expanded target applications and new indications are expected to stimulate the growth of neuromodulation devices and investments and funds.Notable HighlightsInconsistent Reimbursement Policies Due to Lack of Practice Guide LinesNorth America to Maintain Dominance
Key Development in the MarketFDA Clears Xavant Technology’s Stimpod NMS460 Non-Invasive NeuromodulationDevice for Treatment of Chronic Intractable Pain.Companies FeaturedBiocontrol MedicalBoston Scientific CorporationCyberonics Inc.Medtronic Inc.Neuronetics Inc.NeuroPace Inc.NeuroSigma Inc.Nevro CorporationSt. Jude Medical Inc.Synapse Biomedical Inc.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/45v7xk/global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005450/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Neurology Devices
INDUSTRY KEYWORD: SENIORS HEALTH MEDICAL DEVICES CONSUMER
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/06/2018 08:01 AM/DISC: 09/06/2018 08:01 AM